PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.39
5.09M / 4.21M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-0.98%
Negative revenue growth while EXP stands at 8.53%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-70.36%
Negative gross profit growth while EXP is at 20.19%. Joel Greenblatt would examine cost competitiveness or demand decline.
-93.49%
Negative EBIT growth while EXP is at 18.75%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-93.49%
Negative operating income growth while EXP is at 18.75%. Joel Greenblatt would press for urgent turnaround measures.
-0.98%
Negative net income growth while EXP stands at 29.75%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.04%
Slight or no buybacks while EXP is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
-0.02%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
304.81%
10Y revenue/share CAGR 1.25-1.5x EXP's 268.75%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
66.22%
5Y revenue/share CAGR 1.25-1.5x EXP's 45.35%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
39.44%
3Y revenue/share CAGR above 1.5x EXP's 24.81%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
231.47%
Net income/share CAGR at 50-75% of EXP's 396.34%. Martin Whitman might question if the firm’s product or cost base lags behind.
10.49%
Positive 5Y CAGR while EXP is negative. John Neff might view this as a strong mid-term relative advantage.
69.39%
Below 50% of EXP's 152.77%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
No Data
No Data available this quarter, please select a different quarter.
123.77%
5Y equity/share CAGR above 1.5x EXP's 53.18%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
26.51%
3Y equity/share CAGR above 1.5x EXP's 10.98%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.